• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗肿瘤药米托蒽醌和氨甲蒽醌与DNA嵌入复合物的几何结构:分子动力学模拟

The geometry of intercalation complex of antitumor mitoxantrone and ametantrone with DNA: molecular dynamics simulations.

作者信息

Mazerski J, Martelli S, Borowski E

机构信息

Department of Pharmaceutical Technology and Biochemistry, Technical University of Gdańsk, Poland.

出版信息

Acta Biochim Pol. 1998;45(1):1-11.

PMID:9701490
Abstract

Intercalative binding of the antitumor drugs ametantrone and mitoxantrone to the dodecamer duplex d(CGCGAGCTCGCG)2 was studied by applying molecular dynamics in water with the GROMOS 87 force field. A number of reasonable binding orientations were tested by short pre-simulations. It was shown that in energetically favourable orientation the anthraquinone chromophore is perpendicular to the direction of inter-base hydrogen bonds. Helically shaped side-chains of the drugs fit to the minor groove. The best orientation obtained in pre-simulations was applied in the main simulations. Small but significant differences were found between structures of intercalation complexes of the two drugs with the dodecamer duplex, the mitoxantrone complex possessing more favourable energy. The molecular nature of interactions responsible for those differences has been discussed.

摘要

采用GROMOS 87力场,通过在水中进行分子动力学模拟,研究了抗肿瘤药物氨甲蒽醌和米托蒽醌与十二聚体双链d(CGCGAGCTCGCG)2的嵌入结合。通过短时间的预模拟测试了许多合理的结合取向。结果表明,在能量有利的取向下,蒽醌发色团垂直于碱基间氢键的方向。药物的螺旋状侧链适合于小沟。预模拟中获得的最佳取向应用于主要模拟。发现两种药物与十二聚体双链的嵌入复合物结构之间存在微小但显著的差异,米托蒽醌复合物具有更有利的能量。讨论了造成这些差异的相互作用的分子性质。

相似文献

1
The geometry of intercalation complex of antitumor mitoxantrone and ametantrone with DNA: molecular dynamics simulations.抗肿瘤药米托蒽醌和氨甲蒽醌与DNA嵌入复合物的几何结构:分子动力学模拟
Acta Biochim Pol. 1998;45(1):1-11.
2
Binding of a macrocyclic bisacridine and ametantrone to CGTACG involves similar unusual intercalation platforms.一种大环双吖啶和氨茴环素与CGTACG的结合涉及相似的异常嵌入平台。
Biochemistry. 2000 Sep 12;39(36):10950-7.
3
A molecular modeling study of B-DNA-intercalation complexes with amsacrine and related 9-anilino-acridines.氨甲喋呤及相关9-苯胺基吖啶与B-DNA嵌入复合物的分子模拟研究
Pharmazie. 1999 Feb;54(2):83-93.
4
The role of side chains in the interaction of new antitumor pyrimidoacridinetriones with DNA: molecular dynamics simulations.侧链在新型抗肿瘤嘧啶并吖啶三酮与DNA相互作用中的作用:分子动力学模拟
Acta Biochim Pol. 2000;47(1):47-57.
5
Molecular modeling study of interaction of anthracenedione class of drug mitoxantrone and its analogs with DNA tetrameric sequences.蒽二酮类药物米托蒽醌及其类似物与 DNA 四聚体序列相互作用的分子建模研究。
Adv Exp Med Biol. 2011;696:385-400. doi: 10.1007/978-1-4419-7046-6_39.
6
On the molecular mechanism of drug intercalation into DNA: a simulation study of the intercalation pathway, free energy, and DNA structural changes.关于药物嵌入DNA的分子机制:嵌入途径、自由能及DNA结构变化的模拟研究
J Am Chem Soc. 2008 Jul 30;130(30):9747-55. doi: 10.1021/ja8001666. Epub 2008 Jul 9.
7
Interactions of mitoxantrone with duplex and triplex DNA studied by electrospray ionization mass spectrometry.通过电喷雾电离质谱法研究米托蒽醌与双链和三链DNA的相互作用。
Rapid Commun Mass Spectrom. 2008 Dec;22(24):4043-8. doi: 10.1002/rcm.3793.
8
The intercalation of imidazoacridinones into DNA induces conformational changes in their side chain.咪唑并吖啶酮嵌入DNA会导致其侧链发生构象变化。
Acta Biochim Pol. 2000;47(1):65-78.
9
Molecular dynamic simulations of the intercalation of benzothiopyranoindazole anticancer analogs with DNA models.苯并噻吩并吲哚唑抗癌类似物与DNA模型插层的分子动力学模拟
Anticancer Drug Des. 1992 Jun;7(3):181-201.
10
Molecular mechanics and molecular dynamics studies of the intercalation of dynemicin-A with oligonucleotide models of DNA.动态霉素A与DNA寡核苷酸模型嵌入作用的分子力学和分子动力学研究
Mol Pharmacol. 1991 Dec;40(6):1023-8.

引用本文的文献

1
Discovery of PPAR Alpha Lipid Pathway Modulators That Do Not Bind Directly to the Receptor as Potential Anti-Cancer Compounds.发现不直接与受体结合的过氧化物酶体增殖物激活受体α脂质途径调节剂作为潜在的抗癌化合物。
Int J Mol Sci. 2025 Jan 16;26(2):736. doi: 10.3390/ijms26020736.
2
Investigation of the inhibitory behavior of XFE and mitoxantrone molecules in interaction with AKT1 protein: a molecular dynamics simulation study.XFE和米托蒽醌分子与AKT1蛋白相互作用的抑制行为研究:一项分子动力学模拟研究
J Mol Model. 2023 Apr 22;29(5):153. doi: 10.1007/s00894-023-05520-9.
3
Potential Inhibitors of SARS-CoV-2 Main Protease (M) Identified from the Library of FDA-Approved Drugs Using Molecular Docking Studies.
通过分子对接研究从美国食品药品监督管理局(FDA)批准的药物库中鉴定出的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)主要蛋白酶(M)的潜在抑制剂。
Biomedicines. 2022 Dec 29;11(1):85. doi: 10.3390/biomedicines11010085.
4
Cannabidiol Interacts Antagonistically with Cisplatin and Additively with Mitoxantrone in Various Melanoma Cell Lines-An Isobolographic Analysis.大麻二酚在多种黑素瘤细胞系中与顺铂呈拮抗作用,并与米托蒽醌呈相加作用-一项立体化学分析。
Int J Mol Sci. 2022 Jun 17;23(12):6752. doi: 10.3390/ijms23126752.
5
B Cells and Antibodies as Targets of Therapeutic Intervention in Neuromyelitis Optica Spectrum Disorders.作为视神经脊髓炎谱系障碍治疗干预靶点的B细胞和抗体
Pharmaceuticals (Basel). 2021 Jan 6;14(1):37. doi: 10.3390/ph14010037.
6
Liposomal Delivery of Mitoxantrone and a Cholesteryl Indoximod Prodrug Provides Effective Chemo-immunotherapy in Multiple Solid Tumors.米托蒽醌和胆固醇吲哚莫德前药的脂质体递送在多种实体瘤中提供有效的化学免疫疗法。
ACS Nano. 2020 Oct 27;14(10):13343-13366. doi: 10.1021/acsnano.0c05194. Epub 2020 Sep 25.
7
Differential Effects of MS Therapeutics on B Cells-Implications for Their Use and Failure in AQP4-Positive NMOSD Patients.多发性硬化症治疗药物对 B 细胞的差异化影响 - 对 AQP4 阳性 NMOSD 患者的应用和失败的启示。
Int J Mol Sci. 2020 Jul 16;21(14):5021. doi: 10.3390/ijms21145021.
8
Investigation of multicellular tumor spheroids enriched for a cancer stem cell phenotype.对富含癌症干细胞表型的多细胞肿瘤球体的研究。
Stem Cell Investig. 2019 Aug 5;6:21. doi: 10.21037/sci.2019.06.07. eCollection 2019.
9
Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, NCC-dCS1-C1.建立并鉴定一种新型去分化软骨肉瘤细胞系,NCC-dCS1-C1。
Hum Cell. 2019 Apr;32(2):202-213. doi: 10.1007/s13577-018-00232-2. Epub 2019 Feb 8.
10
A Selective and Cell-Permeable Mitochondrial Calcium Uniporter (MCU) Inhibitor Preserves Mitochondrial Bioenergetics after Hypoxia/Reoxygenation Injury.一种具有选择性且可穿透细胞的线粒体钙单向转运体(MCU)抑制剂在缺氧/复氧损伤后可维持线粒体生物能量学。
ACS Cent Sci. 2019 Jan 23;5(1):153-166. doi: 10.1021/acscentsci.8b00773. Epub 2019 Jan 4.